Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
个性化树突状细胞注射液ZSNeo-DC1.1治疗复发或进展的高级别脑胶质瘤I期临床试验
[Translation] Phase I clinical trial of personalized dendritic cell injection ZSNeo-DC1.1 for the treatment of recurrent or progressive high-grade brain glioma
评估个性化树突状细胞注射液ZSNeo-DC1.1治疗复发或进展的高级别脑胶质瘤的安全性、耐受性以及初步有效性;
探索个性化树突状细胞注射液ZSNeo-DC1.1 治疗后,复发或进展的高级别脑胶质瘤受试者对治疗的免疫响应及其特征。
[Translation] To evaluate the safety, tolerability and preliminary efficacy of personalized dendritic cell injection ZSNeo-DC1.1 in the treatment of recurrent or progressive high-grade glioma; to explore the immune response and characteristics of subjects with recurrent or progressive high-grade glioma after personalized dendritic cell injection ZSNeo-DC1.1 treatment.
/ Active, not recruitingPhase 1 个性化树突状细胞注射液ZSNeo-DC1.1治疗恶性实体肿瘤的I期临床试验
[Translation] Phase I clinical trial of personalized dendritic cell injection ZSNeo-DC1.1 in the treatment of malignant solid tumors
主要研究目的:
评估个性化树突状细胞注射液ZSNeo-DC1.1治疗恶性实体肿瘤的安全性和耐受性。
次要研究目的:
评估个性化树突状细胞注射液ZSNeo-DC1.1治疗恶性实体肿瘤的初步有效性。
探索性目的:
探索个性化树突状细胞注射液ZSNeo-DC1.1治疗后,恶性实体瘤受试者对治疗的免疫响应及特征。
[Translation] Primary study objectives:
To evaluate the safety and tolerability of personalized dendritic cell injection ZSNeo-DC1.1 in the treatment of malignant solid tumors.
Secondary study objectives:
To evaluate the preliminary efficacy of personalized dendritic cell injection ZSNeo-DC1.1 in the treatment of malignant solid tumors.
Exploratory objectives:
To explore the immune response and characteristics of subjects with malignant solid tumors after treatment with personalized dendritic cell injection ZSNeo-DC1.1.
100 Clinical Results associated with Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.
0 Patents (Medical) associated with Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.
100 Deals associated with Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.
100 Translational Medicine associated with Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.